Deal Announcements

Intrexon Ingests $10 Million Series C Funding

Thursday, June 25, 2009 5:51:00 AM PDT | VentureDeal Staff

Blacksburg, Virginia  --  Biotechnology company Intrexon Corp. has raised $10 million in its series C round of institutional venture capital funding.

Intrexon is developing modular DNA control systems to enhance the capabilities and lower the costs in "therapeutics, human protein production, and other life science sectors."

Investors in the round included Third Security LLC and other undisclosed investors. Proceeds purposes from the financing were not disclosed.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1